{"id":"https://openalex.org/W2067970495","doi":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","title":"A postmarketing study of relative abuse liability of hypnotic sedative drugs","display_name":"A postmarketing study of relative abuse liability of hypnotic sedative drugs","alternate_titles":[],"publication_year":2004,"publication_date":"2004-02-01","ids":{"openalex":"https://openalex.org/W2067970495","doi":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","mag":"2067970495","pmid":"https://pubmed.ncbi.nlm.nih.gov/14756709"},"language":"en","primary_location":{"id":"doi:10.1111/j.1360-0443.2003.00631.x","doi":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2067970495"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047282391","display_name":"Jerome H. Jaffe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jerome H. Jaffe","raw_affiliation_strings":["Best Practice Project Management, Inc., Bethesda, MD 20814, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Best Practice Project Management, Inc., Bethesda, MD 20814, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090702923","display_name":"Roger N Bloor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124891","display_name":"Harplands Hospital","ror":"https://ror.org/02se1sp19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801607017","https://openalex.org/I4210124891"]},{"id":"https://openalex.org/I56007636","display_name":"Keele University","ror":"https://ror.org/00340yn33","country_code":"GB","type":"education","lineage":["https://openalex.org/I56007636"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger Bloor","raw_affiliation_strings":["Keele University Medical School, Harplands Hospital, Stoke on Trent, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keele University Medical School, Harplands Hospital, Stoke on Trent, UK","institution_ids":["https://openalex.org/I4210124891","https://openalex.org/I56007636"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105939273","display_name":"ILANA B. CROME","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124891","display_name":"Harplands Hospital","ror":"https://ror.org/02se1sp19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801607017","https://openalex.org/I4210124891"]},{"id":"https://openalex.org/I56007636","display_name":"Keele University","ror":"https://ror.org/00340yn33","country_code":"GB","type":"education","lineage":["https://openalex.org/I56007636"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ilana Crome","raw_affiliation_strings":["Keele University Medical School, Harplands Hospital, Stoke on Trent, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keele University Medical School, Harplands Hospital, Stoke on Trent, UK","institution_ids":["https://openalex.org/I4210124891","https://openalex.org/I56007636"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073588355","display_name":"Malcolm Carr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malcolm Carr","raw_affiliation_strings":["Detox 5, Harrogate, North Yorkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Detox 5, Harrogate, North Yorkshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111601913","display_name":"Farrukh Alam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Farrukh Alam","raw_affiliation_strings":["Detox 5, Harrogate, North Yorkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Detox 5, Harrogate, North Yorkshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065215538","display_name":"Arnol Simmons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arnol Simmons","raw_affiliation_strings":["and Best Practice, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and Best Practice, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067952749","display_name":"Roger E. Meyer","orcid":"https://orcid.org/0000-0003-2507-6311","observed_orcids":["https://orcid.org/0000-0003-2507-6311"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roger E. Meyer","raw_affiliation_strings":["and Best Practice, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and Best Practice, Bethesda, MD, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067952749"],"corresponding_institution_ids":[],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":3.2809,"has_fulltext":false,"cited_by_count":73,"citation_normalized_percentile":{"value":0.91160964,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"99","issue":"2","first_page":"165","last_page":"173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.057999998331069946,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.8040000200271606},{"id":"https://openalex.org/keywords/sedative-hypnotics","display_name":"sedative-hypnotic drugs","score":0.9259999990463257},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9539999961853027},{"id":"https://openalex.org/keywords/non-benzodiazepine-hypnotics","display_name":"non-benzodiazepine hypnotics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.906000018119812},{"id":"https://openalex.org/keywords/antihistamines","display_name":"antihistamines","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.7139999866485596},{"id":"https://openalex.org/keywords/addiction-treatment-patients","display_name":"addiction treatment patients","score":0.6949999928474426},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.7170000076293945},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.890999972820282},{"id":"https://openalex.org/keywords/temazepam","display_name":"temazepam","score":0.8740000128746033},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.9409999847412109},{"id":"https://openalex.org/keywords/zopiclone","display_name":"zopiclone","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C3018251022","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Abuse liability","level":3,"score":0.8272048234939575},{"id":"https://openalex.org/C2910067630","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Sedative/hypnotic","level":3,"score":0.7329341173171997},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6484693884849548},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5914640426635742},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.5125048160552979},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.460869163274765},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3886656165122986},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35802310705184937},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35425350069999695},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.28001052141189575},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.259040892124176}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016000","descriptor_name":"Cluster Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D040541","descriptor_name":"Marketing","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1360-0443.2003.00631.x","doi":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2003.00631.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:14756709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14756709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W56187986","https://openalex.org/W61490773","https://openalex.org/W1584229443","https://openalex.org/W1915339567","https://openalex.org/W1965422376","https://openalex.org/W2006494729","https://openalex.org/W2008327202","https://openalex.org/W2012487371","https://openalex.org/W2024241608","https://openalex.org/W2057443980","https://openalex.org/W2071241926","https://openalex.org/W2075450210","https://openalex.org/W2081300445","https://openalex.org/W2081400997","https://openalex.org/W2087546370","https://openalex.org/W2114439374","https://openalex.org/W2290279581","https://openalex.org/W2410376361","https://openalex.org/W2441453331","https://openalex.org/W2471811107","https://openalex.org/W2951695347","https://openalex.org/W3080878207","https://openalex.org/W4302391186","https://openalex.org/W4322694688"],"related_works":["https://openalex.org/W157022601","https://openalex.org/W2042996833","https://openalex.org/W4322694688","https://openalex.org/W2036557105","https://openalex.org/W7135438662","https://openalex.org/W1917052505","https://openalex.org/W2254678939","https://openalex.org/W2471489211","https://openalex.org/W2324986561"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"demonstrate":[2],"the":[3,18,65,94,109,146,190,231],"utility":[4],"of":[5,22,36,46,93,108,183,192,194,203,210],"postmarketing":[6,165],"studies":[7],"using":[8],"in-treatment":[9],"drug":[10,169,173],"and":[11,41,85,151,206,226,234],"alcohol":[12],"abusers":[13],"as":[14,100,113],"informants":[15],"for":[16,132],"assessing":[17],"relative":[19],"abuse":[20,47,104,119,142,184,223],"liability":[21,105,120,143,224],"sedative-hypnotic":[23],"drugs.":[24],"DESIGN:":[25],"A":[26],"survey":[27],"was":[28],"conducted":[29],"that":[30,164,189,202,209],"ascertained":[31],"exposure":[32],"to":[33,59,126,134,208,218,229],"a":[34],"variety":[35],"drugs":[37,111],"with":[38,180],"hypnotic/sedative":[39],"properties":[40],"elicited":[42],"subjective":[43],"evaluations":[44],"indicative":[45],"liability.":[48,185],"METHODS:":[49],"Complete":[50],"data":[51,178,187],"were":[52,69],"obtained":[53,171],"from":[54,172],"297":[55],"admissions":[56],"(78%":[57],"male)":[58],"three":[60,80],"addiction":[61,133],"treatment":[62,176],"sites":[63],"in":[64],"United":[66],"Kingdom.":[67],"Subjects":[68],"asked":[70],"15":[71],"questions":[72],"about":[73],"12":[74],"different":[75],"drugs,":[76,205],"including":[77],"five":[78],"benzodiazepines,":[79],"antidepressants,":[81],"two":[82,86],"non-benzodiazepine":[83,152,196],"hypnotics":[84,153,197],"antihistamines":[87,137],"(plus":[88],"one":[89],"fictitious":[90],"drug).":[91,135],"Three":[92],"benzodiazepines":[95],"(diazepam,":[96],"nitrazipam,":[97],"temazepam)":[98],"emerged":[99],"having":[101],"substantially":[102],"more":[103],"than":[106,201],"any":[107],"other":[110,181],"tested,":[112],"revealed":[114],"by":[115],"higher":[116],"scores":[117],"on":[118,123,167],"items":[121],"(purchased":[122],"street,":[124],"taken":[125],"get":[127],"high,":[128],"like":[129],"drug,":[130],"potential":[131],"The":[136,186,213],"(chlorpheniramine,":[138],"diphenhydramine)":[139],"had":[140,156],"lowest":[141],"profiles,":[144],"while":[145],"antidepressants":[147],"(amitriptyline,":[148],"fluoxetine,":[149],"trazadone)":[150],"(zolpidem,":[154],"zopiclone)":[155],"similar":[157,207],"profiles.":[158],"CONCLUSION:":[159],"This":[160],"pilot":[161],"study":[162],"suggests":[163],"information":[166],"hypnotic":[168],"use":[170],"addicts":[174],"entering":[175],"produces":[177],"consistent":[179],"measures":[182],"suggest":[188],"risk":[191],"misuse":[193],"newer":[195],"may":[198,216,227],"be":[199],"less":[200],"benzodiazepine":[204],"sedating":[211],"antidepressants.":[212],"new":[214],"methodology":[215],"serve":[217],"clarify":[219],"or":[220],"validate":[221],"premarketing":[222],"data,":[225],"help":[228],"inform":[230],"regulatory":[232],"process":[233],"physician":[235],"practice.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2067970495","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
